UnitedHealth Group Management
Management criteria checks 3/4
UnitedHealth Group's CEO is Steve Hemsley, appointed in May 2025, has a tenure of less than a year. directly owns 0.12% of the company’s shares, worth $379.48M. The average tenure of the management team and the board of directors is 3.3 years and 7.3 years respectively.
Key information
Steve Hemsley
Chief executive officer
US$856.2k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.1% |
| Management average tenure | 3.3yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
UnitedHealth's 2026 Could Surprise The Street
Dec 12UnitedHealth Group Incorporated (NYSE:UNH) Held Back By Insufficient Growth Even After Shares Climb 30%
Aug 31
Positive Sentiment Still Eludes UnitedHealth Group Incorporated (NYSE:UNH) Following 37% Share Price Slump
May 13
UnitedHealth Group: Why I Never, Ever Use Stop Loss Orders
Apr 24Down 20%, Still A Buy: Why I'm Doubling Down On UnitedHealth Group
Apr 17UnitedHealth Group: Why Gains On CMS Rate Decision May Not Be Extended
Apr 09UnitedHealth Group: Will 2025 Finally Be A Normal Year?
Mar 27UnitedHealth: Well Oversold And Undervalued, Despite Significant Headwinds
Feb 24Returns At UnitedHealth Group (NYSE:UNH) Appear To Be Weighed Down
Feb 19UnitedHealth Group: Buy The Dip
Feb 17UnitedHealth Group: Delivered Satisfactory Growth Despite Bumps
Jan 30UnitedHealth Group's (NYSE:UNH) Conservative Accounting Might Explain Soft Earnings
Jan 24UnitedHealth: The Anatomy Of A Bearish Setup With Parameters To Confirm Or Deny (Technical Analysis)
Jan 17UnitedHealth: Looking Ahead To Q4 Earnings
Jan 10UnitedHealth Group Incorporated's (NYSE:UNH) P/E Is On The Mark
Jan 01UnitedHealth Group: Recent Pullback Is A Buying Opportunity For Dividend Growth Investors (Rating Upgrade)
Dec 23Wall Street Lunch: UnitedHealthcare Executive Gunned Down In New York
Dec 04UnitedHealth Group: Preparing For December Investor Day, Buy Reiterated
Nov 21UnitedHealth: Expect A New Normal In CMS Funding - Maintain Buy
Oct 19UnitedHealth's Q3 Earnings Preview: A Tactical Opportunity Of Note
Oct 11UnitedHealth Group's Guidance Is Overly Optimistic
Sep 12UnitedHealth Group: Now Is The Time To Buy This Dividend Compounder
Aug 08UnitedHealth: Q2 2024 Earnings Review, A Panacea For Investor's Fears
Jul 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | US$18b |
| Jun 30 2025 | n/a | n/a | US$21b |
| Mar 31 2025 | n/a | n/a | US$22b |
| Dec 31 2024 | US$856k | n/a | US$14b |
| Sep 30 2024 | n/a | n/a | US$14b |
| Jun 30 2024 | n/a | n/a | US$14b |
| Mar 31 2024 | n/a | n/a | US$15b |
| Dec 31 2023 | US$595k | n/a | US$22b |
| Sep 30 2023 | n/a | n/a | US$22b |
| Jun 30 2023 | n/a | n/a | US$21b |
| Mar 31 2023 | n/a | n/a | US$21b |
| Dec 31 2022 | US$580k | n/a | US$20b |
| Sep 30 2022 | n/a | n/a | US$19b |
| Jun 30 2022 | n/a | n/a | US$18b |
| Mar 31 2022 | n/a | n/a | US$17b |
| Dec 31 2021 | US$575k | n/a | US$17b |
| Sep 30 2021 | n/a | n/a | US$15b |
| Jun 30 2021 | n/a | n/a | US$15b |
| Mar 31 2021 | n/a | n/a | US$17b |
| Dec 31 2020 | US$558k | n/a | US$15b |
| Sep 30 2020 | n/a | n/a | US$17b |
| Jun 30 2020 | n/a | n/a | US$17b |
| Mar 31 2020 | n/a | n/a | US$14b |
| Dec 31 2019 | US$8m | US$881k | US$14b |
| Sep 30 2019 | n/a | n/a | US$13b |
| Jun 30 2019 | n/a | n/a | US$13b |
| Mar 31 2019 | n/a | n/a | US$13b |
| Dec 31 2018 | US$11m | US$1m | US$12b |
Compensation vs Market: Steve's total compensation ($USD856.22K) is below average for companies of similar size in the US market ($USD13.36M).
Compensation vs Earnings: Steve's compensation has increased by more than 20% in the past year.
CEO
Steve Hemsley (72 yo)
Mr. Stephen J. Hemsley, also known as Steve, serves as Chief Executive Officer at UnitedHealth Group Incorporated since May 13, 2025. He has been Non-Independent Non-Executive Chairman of UnitedHealth Grou...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Non-Independent Non-Executive Chairman | less than a year | US$856.22k | 0.12% $ 379.5m | |
| Executive VP | 1.5yrs | US$6.87m | 0.0011% $ 3.5m | |
| Executive VP & Chief People Officer | 3.8yrs | US$6.27m | 0.0012% $ 3.8m | |
| EVP of Governance | less than a year | US$11.45m | 0.0020% $ 6.2m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior VP & Chief Accounting Officer | 10.3yrs | no data | 0.0033% $ 10.1m | |
| Executive VP and Chief Digital & Technology Officer | 3.3yrs | no data | no data | |
| Senior Vice President of Capital Markets Communications & Investor Relations | 3.8yrs | no data | no data | |
| Executive VP & Chief Marketing Officer | 11.9yrs | no data | no data | |
| Executive Vice President & Senior Advisor | 12.9yrs | no data | no data | |
| Chief Strategy & Growth Officer | no data | no data | no data | |
| Executive VP and Chief Physician of Value-Based Care & Innovation | 2.4yrs | no data | no data |
Experienced Management: UNH's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Non-Independent Non-Executive Chairman | 25.8yrs | US$856.22k | 0.12% $ 379.5m | |
| Lead Independent Director | 18.2yrs | US$441.35k | 0.00037% $ 1.1m | |
| Independent Director | 4.1yrs | US$366.57k | 0.00036% $ 1.1m | |
| Independent Director | 8.9yrs | US$400.77k | 0.00067% $ 2.1m | |
| Independent Director | 2.1yrs | US$366.07k | no data | |
| Independent Director | 7.8yrs | US$393.60k | 0.00071% $ 2.2m | |
| Director | less than a year | no data | no data | |
| Independent Director | 6.8yrs | US$390.76k | 0.000030% $ 92.9k | |
| Independent Director | 8.3yrs | US$424.26k | 0.000040% $ 123.9k | |
| Independent Director | 3yrs | US$514.77k | 0.00049% $ 1.5m |
Experienced Board: UNH's board of directors are considered experienced (7.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/15 22:57 |
| End of Day Share Price | 2025/12/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
UnitedHealth Group Incorporated is covered by 47 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Hua Ha | Baird |
| Joshua Raskin | Barclays |